Cuicui Han
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Cuicui Han has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Bingjie Guo
Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China
1 shared publication Luyao Yu
Navy Special Medical Centre, Second Military Medical University
1 shared publication- Luyao Yu
Navy Special Medical Centre, Second Military Medical University/Naval Medical University, Shanghai, China
1 shared publication - Sailong Zhang
Department of Pharmacology, Second Military Medical University/Naval Medical University, Shanghai, China
1 shared publication Wenhui Wu
College of Food Science and Technology, Shanghai Ocean University
1 shared publicationWenjuan Sang
Navy Special Medical Centre, Second Military Medical University
1 shared publication
Latest Publications
- 5 November 2026
- Published by Bentham Science Publishers Ltd. in Current Molecular Medicine
- Vol. 27
Identification of Candidate Targets and Immune Characteristics of Salvianolic Acid E Against Ulcerative Colitis via Integrative Transcriptomic Analysis and Machine Learning
Introduction: Ulcerative colitis (UC) is a chronic inflammatory bowel disease with a complex pathogenesis. This study aims to systematically investigate the mechanism of Salvianolic acid E (SAE) in treating UC by identifying its core molecular targets. Methods: Potential target genes of SAE against UC were screened via differential expression analysis of datasets. Integrated approaches including machine learning algorithms, network pharmacology, molecular docking, immune infiltration analysis, and experimental validation were employed to investigate the binding interactions between SAE and target proteins. Results: A total of 13 potential target genes were identified. Machine learning further refined these to five core genes (SLC23A1, SLC6A14, LCN2, PLA2G2A, and CASP1) as key regulatory factors. Among them, SLC23A1 was significantly downregulated, whereas the other four were significantly upregulated. Molecular docking showed putative interactions between SAE and the target proteins. Immune infiltration analysis revealed strong correlations between the core genes and immune cells such as M2 macrophages, neutrophils, and resting mast cells. Cellular-level validation confirmed the expression patterns of these key genes. Discussion: These five core genes constitute a coordinated pathological axis underlying UC progression, which sequentially involves impaired epithelial barrier function, activated innate immune response, amplified pro-inflammatory lipid signaling, and caspase-1-mediated pyroptosis. The stable binding of SAE to these target proteins supports a multi-target synergistic mechanism: SAE may concurrently correct dysregulated solute transport, suppress pro-inflammatory enzymatic activities, and modulate the colonic immune microenvironment. In particular, the strong associations of core genes with neutrophils, M2 macrophages, and resting mast cells suggest that immunomodulation may serve as a critical potential dimension of SAE’s therapeutic efficacy against UC. Our integrated analytical strategy also provides a replicable paradigm for deciphering the pharmacological mechanisms of multi-target natural compounds. Conclusion: The five candidate regulatory genes and the putative binding of SAE to its key targets provide critical insights into the therapeutic mechanism of SAE in UC, offering novel directions for future UC treatment development.
- 5 November 2026
- Published by Bentham Science Publishers Ltd. in Current Molecular Medicine
- Vol. 27
Identification of Candidate Targets and Immune Characteristics of Salvianolic Acid E Against Ulcerative Colitis via Integrative Transcriptomic Analysis and Machine Learning
Introduction: Ulcerative colitis (UC) is a chronic inflammatory bowel disease with a complex pathogenesis. This study aims to systematically investigate the mechanism of Salvianolic acid E (SAE) in treating UC by identifying its core molecular targets. Methods: Potential target genes of SAE against UC were screened via differential expression analysis of datasets. Integrated approaches including machine learning algorithms, network pharmacology, molecular docking, immune infiltration analysis, and experimental validation were employed to investigate the binding interactions between SAE and target proteins. Results: A total of 13 potential target genes were identified. Machine learning further refined these to five core genes (SLC23A1, SLC6A14, LCN2, PLA2G2A, and CASP1) as key regulatory factors. Among them, SLC23A1 was significantly downregulated, whereas the other four were significantly upregulated. Molecular docking showed putative interactions between SAE and the target proteins. Immune infiltration analysis revealed strong correlations between the core genes and immune cells such as M2 macrophages, neutrophils, and resting mast cells. Cellular-level validation confirmed the expression patterns of these key genes. Discussion: These five core genes constitute a coordinated pathological axis underlying UC progression, which sequentially involves impaired epithelial barrier function, activated innate immune response, amplified pro-inflammatory lipid signaling, and caspase-1-mediated pyroptosis. The stable binding of SAE to these target proteins supports a multi-target synergistic mechanism: SAE may concurrently correct dysregulated solute transport, suppress pro-inflammatory enzymatic activities, and modulate the colonic immune microenvironment. In particular, the strong associations of core genes with neutrophils, M2 macrophages, and resting mast cells suggest that immunomodulation may serve as a critical potential dimension of SAE’s therapeutic efficacy against UC. Our integrated analytical strategy also provides a replicable paradigm for deciphering the pharmacological mechanisms of multi-target natural compounds. Conclusion: The five candidate regulatory genes and the putative binding of SAE to its key targets provide critical insights into the therapeutic mechanism of SAE in UC, offering novel directions for future UC treatment development.
- 22 May 2025
- Published by Taylor & Francis in Arid Land Research and Management
- p. 1-21
Research progress on NAC transcription factors in response to drought stress
- 22 May 2025
- Published by Taylor & Francis in Arid Land Research and Management
- p. 1-21
Research progress on NAC transcription factors in response to drought stress